Evidence map›Paper›PMID 28903924›Full record

ArticleBMJ (Clinical research ed.)2017

Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples.

Richard D Riley, Dan Jackson, Georgia Salanti, Danielle L Burke, Malcolm Price, Jamie Kirkham, Ian R White

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ (Clinical research ed.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers, 50 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed, 50 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 50 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Pooled it
  19. Pooled it
  20. Pooled it

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Richard D RileyResearch Institute for Primary Care and Health Sciences, Keele University, Staffordshire, UK r.riley@keele.ac.uk.
Dan JacksonMRC Biostatistics Unit, Cambridge, UK.
Georgia SalantiInstitute of Social and Preventive Medicine, University of Bern, Switzerland.
Danielle L BurkeResearch Institute for Primary Care and Health Sciences, Keele University, Staffordshire, UK.
Malcolm PriceInstitute of Applied Health Research, University of Birmingham, UK.
Jamie KirkhamMRC North West Hub for Trials Methodology Research, Department of Biostatistics, University of Liverpool, Liverpool, UK.
Ian R WhiteMRC Biostatistics Unit, Cambridge, UK.

Funding

Medical Research Council MC_U105260558Medical Research Council MC_UP_0801/1Medical Research Council MC_UU_12023/21Medical Research Council MR/J013595/1Medical Research Council MR/J013595/2
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Network Meta-Analysis as TopicAntineoplastic Agents, HormonalCardiovascular DiseasesClinical Trials as TopicEndometrial NeoplasmsFemaleFibrinogenHumansMultivariate AnalysisMyocardial InfarctionProgesteroneThrombolytic TherapyTreatment OutcomeAntineoplastic Agents, HormonalFibrinogenProgesterone

Identifiers

PMID28903924
PMCPMC5596393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.